TSHA logo

Taysha Gene Therapies, Inc. (TSHA) Accounts Payable

Annual Accounts Payable:

$3.59M-$2.77M(-43.58%)
December 31, 2024

Summary

  • As of today, TSHA annual accounts payable is $3.59 million, with the most recent change of -$2.77 million (-43.58%) on December 31, 2024.
  • During the last 3 years, TSHA annual accounts payable has fallen by -$18.17 million (-83.49%).
  • TSHA annual accounts payable is now -83.49% below its all-time high of $21.76 million, reached on December 31, 2021.

Performance

TSHA Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTSHAbalance sheet metrics

Quarterly Accounts Payable:

$5.44M-$2.27M(-29.50%)
September 30, 2025

Summary

  • As of today, TSHA quarterly accounts payable is $5.44 million, with the most recent change of -$2.27 million (-29.50%) on September 30, 2025.
  • Over the past year, TSHA quarterly accounts payable has increased by +$506.00 thousand (+10.26%).
  • TSHA quarterly accounts payable is now -50.32% below its all-time high of $10.95 million, reached on December 31, 2022.

Performance

TSHA Quarterly Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTSHAbalance sheet metrics

Accounts Payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

TSHA Accounts Payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-43.6%+10.3%
3Y3 Years-83.5%+100.0%
5Y5 Years+100.0%+100.0%

TSHA Accounts Payable Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-83.5%at low-50.3%>+9999.0%
5Y5-Year-83.5%>+9999.0%-50.3%>+9999.0%
All-TimeAll-Time-83.5%>+9999.0%-50.3%>+9999.0%

TSHA Accounts Payable History

DateAnnualQuarterly
Sep 2025
-
$5.44M(-29.5%)
Jun 2025
-
$7.71M(+78.3%)
Mar 2025
-
$4.33M(+20.4%)
Dec 2024
$3.59M(-43.6%)
$3.59M(-27.2%)
Sep 2024
-
$4.93M(-43.4%)
Jun 2024
-
$8.72M(-16.0%)
Mar 2024
-
$10.38M(+63.1%)
Dec 2023
$6.37M(-41.8%)
$6.37M(-15.3%)
Sep 2023
-
$7.52M(-30.2%)
Jun 2023
-
$10.77M(+19.6%)
Mar 2023
-
$9.00M(-17.8%)
Dec 2022
$10.95M
$10.95M(>+9900.0%)
DateAnnualQuarterly
Sep 2022
-
$0.00(0.0%)
Jun 2022
-
$0.00(0.0%)
Mar 2022
-
$0.00(0.0%)
Dec 2021
$21.76M(+991.4%)
$0.00(0.0%)
Sep 2021
-
$0.00(-100.0%)
Jun 2021
-
$6.36M(+55.6%)
Mar 2021
-
$4.08M(>+9900.0%)
Dec 2020
$1.99M(>+9900.0%)
-
Dec 2020
-
$0.00(0.0%)
Sep 2020
-
$0.00(-100.0%)
Jun 2020
-
$1.25M
Dec 2019
$0.00
-

FAQ

  • What is Taysha Gene Therapies, Inc. annual accounts payable?
  • What is the all-time high annual accounts payable for Taysha Gene Therapies, Inc.?
  • What is Taysha Gene Therapies, Inc. annual accounts payable year-on-year change?
  • What is Taysha Gene Therapies, Inc. quarterly accounts payable?
  • What is the all-time high quarterly accounts payable for Taysha Gene Therapies, Inc.?
  • What is Taysha Gene Therapies, Inc. quarterly accounts payable year-on-year change?

What is Taysha Gene Therapies, Inc. annual accounts payable?

The current annual accounts payable of TSHA is $3.59M

What is the all-time high annual accounts payable for Taysha Gene Therapies, Inc.?

Taysha Gene Therapies, Inc. all-time high annual accounts payable is $21.76M

What is Taysha Gene Therapies, Inc. annual accounts payable year-on-year change?

Over the past year, TSHA annual accounts payable has changed by -$2.77M (-43.58%)

What is Taysha Gene Therapies, Inc. quarterly accounts payable?

The current quarterly accounts payable of TSHA is $5.44M

What is the all-time high quarterly accounts payable for Taysha Gene Therapies, Inc.?

Taysha Gene Therapies, Inc. all-time high quarterly accounts payable is $10.95M

What is Taysha Gene Therapies, Inc. quarterly accounts payable year-on-year change?

Over the past year, TSHA quarterly accounts payable has changed by +$506.00K (+10.26%)
On this page